HRB
40
3
DGX
28
4
MSI
52
3
GM
55
6
GILD
55
5
HBAN
47
7
UHS
50
4
EMR
57
7
NI
63
5
EBAY
42
2
DTE
49
16
FOX
71
3
DG
14
6
ALL
37
3
URBN
67
3
KLAC
45
3
CCI
30
2
V
70
14
MCO
67
3
IRM
33
5
HRB
40
3
DGX
28
4
MSI
52
3
GM
55
6
GILD
55
5
HBAN
47
7
UHS
50
4
EMR
57
7
NI
63
5
EBAY
42
2
DTE
49
16
FOX
71
3
DG
14
6
ALL
37
3
URBN
67
3
KLAC
45
3
CCI
30
2
V
70
14
MCO
67
3
IRM
33
5
Financhill
Back

Omega Therapeutics 10K Form

Sell
25

OMGA
Omega Therapeutics

Last Price:
$0.83
Seasonality Move:
22.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMGA News And Ratings

See the #1 stock for the next 7 days that we like better than OMGA

OMGA Financial Statistics

Sales & Book Value

Annual Sales: $3.1M
Cash Flow: $-14M
Price / Cash Flow: 0
Annual Sales: $0.21
Price / Book: 3.98

Profitability

EPS (TTM): -1.32000
Net Income (TTM): $-73.1M
Gross Margin: --
Return on Equity: -171.4%
Return on Assets: -39.43%

Omega Therapeutics Earnings Forecast

Key Omega Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,494.15% of Revenue.
  • The Interest Expense is -1.33% of Operating Income.
  • The Net Earning history of OMGA is -3,148.93% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Omega Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: OMGA
Website: omegatherapeutics.com

Debt

Debt-to-Equity Ratio: 1.35
Current Ratio: 1.61
Quick Ratio: 1.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMGA Technical Analysis vs Fundamental Analysis

Sell
25
Omega Therapeutics (OMGA) is a Sell

Is Omega Therapeutics a Buy or a Sell?